Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Trademark Search
BRISTOL MYERS SQUIBB & DESIGN
ADVERTISED
on 25 Sep 2024
Last Applicant/ Owned by
BRISTOL-MYERS SQUIBB CANADA CO./LA SOCIÉTÉ BRISTOL-MYERS SQUIBB CANADA
2344 Alfred-Nobel BoulevardSuite 300Montreal
QUEBEC
CA
H4S0A4
Serial Number
2054552 filed on 29th Sep 2020
Correspondent Address
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
BRISTOL MYERS SQUIBB & DESIGN
Vienna Information
2 . 9 . 14
Hands, folded hands, fingers, handprints or fingerprints, armsMains, mains jointes, doigts, empreintes de mains ou de doigts, bras
2 . 9 . 15
Open hands (palm or back)Mains de face (paume ou revers)
29 . 1 . 5
VioletViolet
Trademark usage description
pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosi Read MoreClassification Information
Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies; pharmaceutical preparations for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use; radiopharmaceuticals;
Classification kind code
11
Class [042]
Pharmaceutical research and development services
Classification kind code
11
Class [044]
Medical services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; medical services, namely, providing information in the field of healthcare and pharmaceuticals via a website
Classification kind code
11
Mark Details
Serial Number
2054552
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 42 on 25th Sep 2024 | Advertised |
| Submitted for opposition 27 on 29th Aug 2024 | Approval Notice Sent |
| Submitted for opposition 26 on 29th Aug 2024 | Approved |
| Submitted for opposition 22 on 27th Jun 2024 | Search Recorded |
| Submitted for opposition 20 on 27th Jun 2024 | Examiner's First Report |
| Submitted for opposition 287 on 20th Oct 2022 | Pre-Assessment Letter Sent |
| Submitted for opposition 30 on 29th Sep 2020 | Filed |
| Submitted for opposition 1 on 29th Sep 2020 | Created |
| Submitted for opposition 31 on 29th Sep 2020 | Formalized |